Abstract

Researchers and clinicians have made great strides against many cancers but, unfortunately, not all of them. Glioblastoma multiforme (GBM) remains incredibly deadly – the five-year survival rate is a meager 5%. Diffuse intrinsic pontine glioma (DIPG) is an almost universally fatal pediatric brain tumor. The five-year survival is around 2%. GBMs are generally treated with surgery and radiation. DIPG is so thoroughly embedded in the pons that surgery is impossible. Radiation can provide some small relief, and clinicians have seen some promise in CAR-T therapy. [3] However, the gains are uncertain and the cost in side effects quite high.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.